Sancuso
These highlights do not include all the information needed to use Sancuso (Granisetron Transdermal System) safely and effectively. See full prescribing information for Sancuso. Sancuso (Granisetron Transdermal System) Initial U.S. Approval: 2008
Approved
Approval ID
9aed2020-1827-4f13-99df-191c492c11f9
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Sep 30, 2009
Manufacturers
FDA
Physicians Total Care, Inc.
DUNS: 194123980
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
granisetron
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code54868-5985
Application NumberNDA022198
Product Classification
M
Marketing Category
C73594
G
Generic Name
granisetron
Product Specifications
Route of AdministrationTRANSDERMAL
Effective DateNovember 1, 2011
FDA Product Classification
INGREDIENTS (1)
GRANISETRONActive
Quantity: 3.1 mg in 24 h
Code: WZG3J2MCOL
Classification: ACTIB